|
|
|
| Relationship between Serum IL-6 PCT and CRP Levels and Prognosis of Neonatal Sepsis |
| XU Aihua, GU Tao, LI Yun, et al |
| The First People's Hospital of Chuzhou City, Anhui Chuzhou 239000, China |
|
|
|
|
Abstract Objective: To investigate the relationship between serum interleukin-6 (IL-6), procalcitonin (PCT), and C-reactive protein (CRP) levels and the prognosis of neonatal sepsis. Methods: A total of 86 neonates with sepsis admitted to our hospital from August 2020 to March 2023 were enrolled as the study subjects. The general data of the cured/improved group and the death group were analyzed. The serum IL-6, PCT, and CRP levels of the neonates in the two groups at different time points were compared, and the factors affecting the prognosis of neonates with sepsis were analyzed. Results: Among the 86 neonates with sepsis, there were 77 neonates in the cured/improved group and 9 neonates in the death group (4 neonates died within 12 hours, 2 died within 2 days, 2 died within 3 days, and 1 died within 5 days). The percentages of IL-6 > 7 pg/mL, PCT > 0.5 ng/mL, and CRP > 10 mg/mL in the death group were higher than those in the cured/improved group at 12 hours, 12-36 hours, and 7 days after onset (P < 0.05). There were no statistically significant differences in gender, premature rupture of membranes, preterm birth, jaundice, and delivery method between the two groups (P > 0.05). The gestational age, birth weight, and Ages & Stages Questionnaires (ASQ) at 0-6 years old were significantly different between the two groups (P < 0.05). Multivariate logistic regression analysis showed that ASQ at 0-6 years old, IL-6, PCT, and CRP were independent risk factors for the prognosis of neonatal sepsis (P < 0.001). Conclusion: Serum IL-6, PCT, and CRP levels are related factors affecting the prognosis of neonates with sepsis. Monitoring serum IL-6, PCT, and CRP levels may provide reliable references for clinical adjustment of treatment strategies for neonatal sepsis.
|
|
|
|
|
|
[1] 池秀芳,陈佳.新生儿败血症病原学及耐药性分析[J].广东医学,2022,43(1):36-39.
[2] 张江玲.个性化干预模式对新生儿败血症的影响[J].中国妇幼保健,2023,38(6):1129-1132.
[3] 庞玮,刘静,侍海棠.新生儿败血症核因子-κB和中性粒细胞CD11b、CD64表达及与病情严重程度的关系[J].中华医院感染学杂志,2022,32(6):902-905.
[4] 刘启星,王斌.IL-6、TNF-α和CRP联合检测在新生儿败血症诊断中的临床意义[J].检验医学与临床,2021,18(15):2272-2274.
[5] 姜毅.新生儿败血症诊疗进展[J].中国新生儿科杂志,2010,25(2):69-72.
[6] Deng Xiaoyao,Tian Zhiliang.Research progress of erythrocyte volume distribution width in neonatal sepsis[J].Chinese Journal of Medical Education,2022,45(3):285-288.
[7] 郭景瑞,高奶荣,祝颖,等.新生儿败血症T淋巴细胞亚群、PCT、CRP、Lac及炎症因子的检测及其临床意义[J].海南医学,2020,31(20):2620-2622.
[8] Liu Qian,Liu Xue-Qin,Yuan Li,et al.Application of peripheral blood T lymphocyte subsets and PCT in diagnosis and prognosis evaluation of neonatal sepsis[J].Chinese Journal of nosocomiolog,2021,31(12):1786-1790.
[9] 潘晓浩,郝建石,黄建芳,等.降钙素原及血清淀粉样蛋白A在诊断新生儿败血症中的临床应用价值[J].中国卫生检验杂志,2022,32(12):1478-1481.
[10] 鲁静.血清降钙素原在新生儿败血症病情和预后评估中的应用价值[J].新乡医学院学报,2021,38(12):1171-1174.
[11] 王晓蔚,何米兰,夏泳波,等.Hs-CRP、CD64、sTREM-1水平联合检测在新生儿败血症诊断中的应用[J].基因组学与应用生物学,2020,39(2):969-974.
[12] 申存存,赵春慧,邱净净,等.降钙素原、C反应蛋白及白细胞参数对新生儿败血症病情诊断的临床意义[J].临床血液学杂志,2022,35(4):256-259. |
|
|
|
2024, Vol. 30 
